Last reviewed · How we verify
R-2487
At a glance
| Generic name | R-2487 |
|---|---|
| Also known as | Probiotic |
| Sponsor | Rise Therapeutics LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- R-2487 in Patients With Rheumatoid Arthritis (PHASE1)
- R-2487 in Patients With Sjogren's Syndrome (SS) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- R-2487 CI brief — competitive landscape report
- R-2487 updates RSS · CI watch RSS
- Rise Therapeutics LLC portfolio CI